Hugh M Cole Jounce Therapeutics, Inc. (JNCE) insider trading activity

JNCE Quotes by TradingView

Hugh M Cole is Chief Operating Officer of Jounce Therapeutics, Inc.. Currently has a direct ownership of 110,082 shares of JNCE, which is worth approximately $0. The most recent transaction as insider was on Jan 10, 2023, when has been sold 9,182 shares (Common Stock) at a price of $1.12 per share, resulting in proceeds of $10,283. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 110K
0% 3M change
0% 12M change
Total Value Held $0

Hugh M Cole Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jan 10 2023
SELL
Open market or private sale
$10,283 $1.12 p/Share
9,182 Reduced 7.7%
110,082 Common Stock
Jan 09 2023
SELL
Open market or private sale
$8,197 $1.1 p/Share
7,452 Reduced 5.88%
119,264 Common Stock
Aug 01 2022
BUY
Grant, award, or other acquisition
-
20,000 Added 13.63%
126,716 Common Stock
Feb 01 2022
BUY
Grant, award, or other acquisition
-
42,500 Added 28.48%
106,716 Common Stock
Jan 10 2022
SELL
Open market or private sale
$41,263 $6.65 p/Share
6,205 Reduced 8.81%
64,216 Common Stock
Jan 07 2022
SELL
Open market or private sale
$25,316 $7.3 p/Share
3,468 Reduced 4.69%
70,421 Common Stock
Feb 01 2021
BUY
Grant, award, or other acquisition
-
26,700 Added 26.54%
73,889 Common Stock
Jan 22 2021
SELL
Open market or private sale
$215,100 $11.95 p/Share
18,000 Reduced 27.61%
47,189 Common Stock
Jan 22 2021
BUY
Exercise of conversion of derivative security
$54,800 $5.48 p/Share
10,000 Added 13.3%
65,189 Common Stock
Jan 08 2021
SELL
Open market or private sale
$23,380 $7.0 p/Share
3,340 Reduced 5.71%
55,189 Common Stock
Jan 07 2021
SELL
Open market or private sale
$19,462 $6.76 p/Share
2,879 Reduced 4.69%
58,529 Common Stock

Also insider at

ATXS
Astria Therapeutics, Inc. Healthcare
Director
HMC

Hugh M Cole

Chief Operating Officer
Cambridge, MA

Track Institutional and Insider Activities on JNCE

Follow Jounce Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells JNCE shares.

Notify only if

Insider Trading

Get notified when an Jounce Therapeutics, Inc. insider buys or sells JNCE shares.

Notify only if

News

Receive news related to Jounce Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on JNCE